Targeting IL-1β and IL-17A driven inflammation during influenza-induced exacerbations of chronic lung inflammation

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Sichelstiel, Anke ^a,b   Yadava, Koshika ^a   Trompette, Aurélien ^a   Salami, Olawale ^a   Iwakura, Yoichiro ^c   Nicod, Laurent P ^a   Marsland, Benjamin J ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 1BETA; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; EMPHYSEMA; IN VITRO STUDY; INFLUENZA; LUNG FUNCTION; LUNG RESISTANCE; MOUSE; NEUTROPHILIA; NONHUMAN; PNEUMONIA; PROTEIN FUNCTION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; VIRUS NEUTRALIZATION; VIRUS REPLICATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; C57BL MOUSE; CHRONIC DISEASE; COMPLICATION; HUMAN; IMMUNOLOGY; INFLUENZA, HUMAN; NEUTROPHIL CHEMOTAXIS; ORTHOMYXOVIRIDAE INFECTIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ANIMALS; ANTIBODIES, NEUTRALIZING; CHRONIC DISEASE; HUMANS; INFLUENZA, HUMAN; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-17; INTERLEUKIN-1BETA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; ORTHOMYXOVIRIDAE INFECTIONS; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECOMBINANT PROTEINS;

EID: 84903398807     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098440     Document Type: Article

References (59)

1. Barnes PJ (2004) Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 56: 515-548.
2. Donaldson GC, Wedzicha JA (2006) COPD exacerbations.1: Epidemiology. Thorax 61: 164-168.
3. Sethi S, Mallia P, Johnston SL (2009) New paradigms in the pathogenesis of chronic obstructive pulmonary disease II. Proc Am Thorac Soc 6: 532-534.
4. Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, et al. (2005) Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60: 925-931. (Pubitemid 41598207)
5. Suissa S, Dell'aniello S, Ernst P (2012) Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax.
6. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, et al. (1998) Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157: 1418-1422.
7. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, et al. (2006) Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 173: 1114-1121. (Pubitemid 43726892)
8. Rohde G, Wiethege A, Borg I, Kauth M, Bauer TT, et al. (2003) Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 58: 37-42. (Pubitemid 36135356)
9. Hurst JR, Donaldson GC, Wilkinson TM, Perera WR, Wedzicha JA (2005) Epidemiological relationships between the common cold and exacerbation frequency in COPD. Eur Respir J 26: 846-852. (Pubitemid 41632041)
10. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, et al. (2001) Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164: 1618-1623. (Pubitemid 33124148)
11. Wedzicha JA (2004) Role of viruses in exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 1: 115-120.
12. Potena A, Caramori G, Casolari P, Contoli M, Johnston SL, et al. (2007) Pathophysiology of viral-induced exacerbations of COPD. Int J Chron Obstruct Pulmon Dis 2: 477-483.
13. Ko FW, Ip M, Chan PK, Chan MC, To KW, et al. (2007) Viral etiology of acute exacerbations of COPD in Hong Kong. Chest 132: 900-908.
14. Tan WC, Xiang X, Qiu D, Ng TP, Lam SF, et al. (2003) Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. Am J Med 115: 272-277. (Pubitemid 37088188)
15. Qiu Y, Zhu J, Bandi V, Atmar RL, Hattotuwa K, et al. (2003) Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 168: 968-975. (Pubitemid 37267175)
16. Aaron SD, Angel JB, Lunau M, Wright K, Fex C, et al. (2001) Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163: 349-355. (Pubitemid 32158511)
17. Gessner C, Scheibe R, Wotzel M, Hammerschmidt S, Kuhn H, et al. (2005) Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease. Respir Med 99: 1229-1240. (Pubitemid 41245308)
18. Bathoorn E, Kerstjens H, Postma D, Timens W, MacNee W (2008) Airways inflammation and treatment during acute exacerbations of COPD. Int J Chron Obstruct Pulmon Dis 3: 217-229. (Pubitemid 352037882)
19. Bauer CM, Zavitz CC, Botelho FM, Lambert KN, Brown EG, et al. (2010) Treating viral exacerbations of chronic obstructive pulmonary disease: insights from a mouse model of cigarette smoke and H1N1 influenza infection. PLoS One 5: e13251.
20. Botelho FM, Bauer CM, Finch D, Nikota JK, Zavitz CC, et al. (2011) IL-1alpha/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice. PLoS One 6: e28457.
21. Churg A, Zhou S, Wang X, Wang R, Wright JL (2009) The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling. Am J Respir Cell Mol Biol 40: 482-490.
22. Couillin I, Vasseur V, Charron S, Gasse P, Tavernier M, et al. (2009) IL-1R1/MyD88 signaling is critical for elastase-induced lung inflammation and emphysema. J Immunol 183: 8195-8202.
23. Doz E, Noulin N, Boichot E, Guenon I, Fick L, et al. (2008) Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. J Immunol 180: 1169-1178.
24. Lappalainen U, Whitsett JA, Wert SE, Tichelaar JW, Bry K (2005) Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol 32: 311-318. (Pubitemid 40478306)
25. Lucey EC, Keane J, Kuang PP, Snider GL, Goldstein RH (2002) Severity of elastase-induced emphysema is decreased in tumor necrosis factor-alpha and interleukin-1beta receptor-deficient mice. Lab Invest 82: 79-85. (Pubitemid 34072648)
26. Pauwels NS, Bracke KR, Dupont LL, Van Pottelberge GR, Provoost S, et al. (2011) Role of IL-1alpha and the Nlrp3/caspase-1/IL-1beta axis in cigarette smoke-induced pulmonary inflammation and COPD. Eur Respir J 38: 1019-1028.
27. Castro P, Legora-Machado A, Cardilo-Reis L, Valenca S, Porto LC, et al. (2004) Inhibition of interleukin-1beta reduces mouse lung inflammation induced by exposure to cigarette smoke. Eur J Pharmacol 498: 279-286. (Pubitemid 39208090)
28. Kersul AL, Iglesias A, Rios A, Noguera A, Forteza A, et al. (2011) Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease. Arch Bronconeumol 47: 176-183.
29. Kythreotis P, Kokkini A, Avgeropoulou S, Hadjioannou A, Anastasakou E, et al. (2009) Plasma leptin and insulin-like growth factor I levels during acute exacerbations of chronic obstructive pulmonary disease. BMC Pulm Med 9: 11.
30. Horai R, Asano M, Sudo K, Kanuka H, Suzuki M, et al. (1998) Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion. J Exp Med 187: 1463-1475. (Pubitemid 28215405)
31. Thurlbeck WM (1967) Measurement of pulmonary emphysema. Am Rev Respir Dis 95: 752-764.
32. Saetta M, Shiner RJ, Angus GE, Kim WD, Wang NS, et al. (1985) Destructive index: a measurement of lung parenchymal destruction in smokers. Am Rev Respir Dis 131: 764-769. (Pubitemid 15066865)
33. Uyttenhove C, Van Snick J (2006) Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis. Eur J Immunol 36: 2868-2874. (Pubitemid 44782560)
34. Sajjan U, Ganesan S, Comstock AT, Shim J, Wang Q, et al. (2009) Elastase- and LPS-exposed mice display altered responses to rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 297: L931-944.
35. Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W (1999) Bacterial endotoxin is an active component of cigarette smoke. Chest 115: 829-835. (Pubitemid 29129968)
36. Larsson L, Szponar B, Pehrson C (2004) Tobacco smoking increases dramatically air concentrations of endotoxin. Indoor Air 14: 421-424. (Pubitemid 39523854)
37. Gaschler GJ, Zavitz CC, Bauer CM, Stampfli MR (2010) Mechanisms of clearance of nontypeable Haemophilus influenzae from cigarette smoke-exposed mouse lungs. Eur Respir J 36: 1131-1142.
38. Han Y, Ling MT, Mao H, Zheng J, Liu M, et al. (2014) Influenza virus-induced lung inflammation was modulated by cigarette smoke exposure in mice. PLoS One 9: e86166.
39. Daffern PJ, Jagels MA, Hugli TE (1999) Multiple epithelial cell-derived factors enhance neutrophil survival. Regulation by glucocorticoids and tumor necrosis factor-alpha. Am J Respir Cell Mol Biol 21: 259-267. (Pubitemid 129502225)
40. Mihara M, Hashizume M, Yoshida H, Suzuki M, Shiina M (2012) IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) 122: 143-159.
41. Di Stefano A, Caramori G, Gnemmi I, Contoli M, Vicari C, et al. (2009) T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin Exp Immunol 157: 316-324.
42. Doe C, Bafadhel M, Siddiqui S, Desai D, Mistry V, et al. (2010) Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest 138: 1140-1147.
43. Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, et al. (2009) Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30: 576-587.
44. Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC (2006) A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 203: 1685-1691. (Pubitemid 44036274)
45. Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, et al. (2009) Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31: 331-341.
46. Wedzicha JA, Seemungal TA (2007) COPD exacerbations: defining their cause and prevention. Lancet 370: 786-796. (Pubitemid 47320802)
47. Hoogendoorn M, Hoogenveen RT, Rutten-van Molken MP, Vestbo J, Feenstra TL (2011) Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach. Eur Respir J 37: 508-515.
48. Balbi B, Bason C, Balleari E, Fiasella F, Pesci A, et al. (1997) Increased bronchoalveolar granulocytes and granulocyte/macrophage colony-stimulating factor during exacerbations of chronic bronchitis. Eur Respir J 10: 846-850. (Pubitemid 27180197)
49. Drost EM, Skwarski KM, Sauleda J, Soler N, Roca J, et al. (2005) Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax 60: 293-300. (Pubitemid 40522365)
50. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA (2000) Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161: 1608-1613. (Pubitemid 30329036)
51. Hacievliyagil SS, Gunen H, Mutlu LC, Karabulut AB, Temel I (2006) Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease. Respir Med 100: 846-854.
52. Chen K, Pociask DA, McAleer JP, Chan YR, Alcorn JF, et al. (2011) IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke. PLoS One 6: e20333.
53. Shan M, Yuan X, Song LZ, Roberts L, Zarinkamar N, et al. (2012) Cigarette smoke induction of osteopontin (SPP1) mediates T(H)17 inflammation in human and experimental emphysema. Sci Transl Med 4: 117ra119.
54. Crowe CR, Chen K, Pociask DA, Alcorn JF, Krivich C, et al. (2009) Critical role of IL-17RA in immunopathology of influenza infection. J Immunol 183: 5301-5310.
55. Calverley PM, Boonsawat W, Cseke Z, Zhong N, Peterson S, et al. (2003) Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur Respir J 22: 912-919. (Pubitemid 37540641)
56. Rennard SI, Tashkin DP, McElhattan J, Goldman M, Ramachandran S, et al. (2009) Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial. Drugs 69: 549-565.
57. Szafranski W, Cukier A, Ramirez A, Menga G, Sansores R, et al. (2003) Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J 21: 74-81. (Pubitemid 36150304)
58. Barnes PJ (2010) Medicine. Neutrophils find smoke attractive. Science 330: 40-41.
59. Perttunen H, Moilanen E, Zhang X, Barnes PJ, Kankaanranta H (2008) Beta2-agonists potentiate corticosteroid-induced neutrophil survival. COPD 5: 163-169. (Pubitemid 351892736)